The latest update is out from Fortrea Holdings Inc. (FTRE).
The Company has recently announced the sale of its Endpoint Clinical and Fortrea Patient Access divisions, signaling a strategic shift in its business focus. This announcement, made public through a press release on March 11, 2024, is not intended for regulatory filing purposes but serves as an informational update to shareholders and the market, outlining the company’s latest operational changes.
See more data about FTRE stock on TipRanks’ Stock Analysis page.
